Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 934

1.

Outpatient management of patients with low-risk pulmonary embolism: another piece of evidence.

Sanchez O, Humbert M.

Eur Heart J. 2019 Jul 13. pii: ehz484. doi: 10.1093/eurheartj/ehz484. [Epub ahead of print] No abstract available.

PMID:
31302693
2.

Characterization of two putative Dichelobacter nodosus footrot vaccine antigens identifies the first lysozyme inhibitor in the genus.

Humbert MV, Jackson A, Orr CM, Tews I, Christodoulides M.

Sci Rep. 2019 Jul 11;9(1):10055. doi: 10.1038/s41598-019-46506-z.

PMID:
31296905
Free Article
3.

Severe T2-high asthma in the biologics era: European experts' opinion.

Pavord I, Bahmer T, Braido F, Cosío BG, Humbert M, Idzko M, Adamek L.

Eur Respir Rev. 2019 Jul 8;28(152). pii: 190054. doi: 10.1183/16000617.0054-2019. Print 2019 Jun 30. Review.

PMID:
31285291
Free Article
4.

High Glass-Transition Temperature Polymer Networks harnessing the Dynamic Ring Opening of Pinacol Boronates.

Brunet J, Collas F, Humbert M, Perrin L, Brunel F, Lacôte E, Montarnal D, Raynaud J.

Angew Chem Int Ed Engl. 2019 Jun 26. doi: 10.1002/anie.201904559. [Epub ahead of print]

PMID:
31241821
5.

Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility.

Humbert M, Albers FC, Bratton DJ, Yancey SW, Liu MC, Hozawa S, Llanos JP, Kwon N.

Respir Med. 2019 Jul - Aug;154:69-75. doi: 10.1016/j.rmed.2019.06.004. Epub 2019 Jun 8.

PMID:
31220806
6.

Neutralization of CXCL12 attenuates established pulmonary hypertension in rats.

Bordenave J, Thuillet R, Tu L, Phan C, Cumont A, Marsol C, Huertas A, Savale L, Hibert M, Galzi JL, Bonnet D, Humbert M, Frossard N, Guignabert C.

Cardiovasc Res. 2019 Jun 7. pii: cvz153. doi: 10.1093/cvr/cvz153. [Epub ahead of print]

PMID:
31173066
7.

Pulmonary arterial hypertension in patient treated for multiple sclerosis with 4-aminopyridine.

Antigny F, Chaumais MC, Humbert M, Montani D.

Fundam Clin Pharmacol. 2019 Aug;33(4):426-427. doi: 10.1111/fcp.12489. Epub 2019 Jun 26. No abstract available.

PMID:
31148228
8.

Cloning, Expression, and Purification of Recombinant Neisseria gonorrhoeae Proteins.

Humbert MV.

Methods Mol Biol. 2019;1997:233-266. doi: 10.1007/978-1-4939-9496-0_15.

PMID:
31119628
9.

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?

Margelidon-Cozzolino V, Delavenne X, Catella-Chatron J, De Magalhaes E, Bezzeghoud S, Humbert M, Montani D, Bertoletti L.

Blood Rev. 2019 May 15. pii: S0268-960X(19)30019-0. doi: 10.1016/j.blre.2019.05.003. [Epub ahead of print] Review.

PMID:
31113643
10.

Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension.

Taniguchi Y, Jaïs X, Jevnikar M, Boucly A, Weatherald J, Brenot P, Planche O, Parent F, Savale L, Fadel E, Montani D, Humbert M, Sitbon O, Simonneau G.

J Heart Lung Transplant. 2019 Apr 27. pii: S1053-2498(19)31474-3. doi: 10.1016/j.healun.2019.04.006. [Epub ahead of print]

PMID:
31103383
11.

Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.

Hoette S, Creuzé N, Rochitte CE, Simonneau G, Humbert M, Souza R, Chemla D.

Pulmonology. 2019 Jul - Aug;25(4):248-251. doi: 10.1016/j.pulmoe.2019.03.002. Epub 2019 May 10.

12.

Prostacyclin for pulmonary arterial hypertension.

Barnes H, Yeoh HL, Fothergill T, Burns A, Humbert M, Williams T.

Cochrane Database Syst Rev. 2019 May 1;5:CD012785. doi: 10.1002/14651858.CD012785.pub2. Review.

PMID:
31042010
13.

French experience of balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.

Brenot P, Jaïs X, Taniguchi Y, Garcia Alonso C, Gerardin B, Mussot S, Mercier O, Fabre D, Parent F, Jevnikar M, Montani D, Savale L, Sitbon O, Fadel E, Humbert M, Simonneau G.

Eur Respir J. 2019 May 18;53(5). pii: 1802095. doi: 10.1183/13993003.02095-2018. Print 2019 May.

PMID:
31023842
14.

Response by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension".

Guignabert C, Tu L, Feige JJ, Humbert M, Bailly S.

Circ Res. 2019 Apr 26;124(9):e82-e83. doi: 10.1161/CIRCRESAHA.119.315053. No abstract available.

PMID:
31021726
15.

[New insights in the pathogenesis of pulmonary arterial hypertension].

Bordenave J, Tu L, Savale L, Huertas A, Humbert M, Guignabert C.

Rev Mal Respir. 2019 Apr;36(4):433-437. doi: 10.1016/j.rmr.2019.03.003. Epub 2019 Apr 19. French.

PMID:
31010759
16.

An insider view on the World Symposium on Pulmonary Hypertension.

Humbert M, Galiè N, McLaughlin VV, Rubin LJ, Simonneau G.

Lancet Respir Med. 2019 Jun;7(6):484-485. doi: 10.1016/S2213-2600(19)30111-0. Epub 2019 Apr 4. No abstract available.

PMID:
30956061
17.

The BET Bromodomain Inhibitor I-BET-151 Induces Structural and Functional Alterations of the Heart Mitochondria in Healthy Male Mice and Rats.

Piquereau J, Boet A, Péchoux C, Antigny F, Lambert M, Gressette M, Ranchoux B, Gambaryan N, Domergue V, Mumby S, Montani D, Adcock IM, Humbert M, Garnier A, Rucker-Martin C, Perros F.

Int J Mol Sci. 2019 Mar 27;20(7). pii: E1527. doi: 10.3390/ijms20071527.

18.

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.

Humbert M, Bousquet J, Bachert C, Palomares O, Pfister P, Kottakis I, Jaumont X, Thomsen SF, Papadopoulos NG.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27. Review.

19.

Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.

Günther S, Perros F, Rautou PE, Girerd B, Ghigna MR, Cazals-Hatem D, Lau EM, Dorfmüller P, Sitbon O, Valla DC, Humbert M, Montani D.

Am J Pathol. 2019 Jun;189(6):1159-1175. doi: 10.1016/j.ajpath.2019.02.007. Epub 2019 Mar 26. Review.

PMID:
30926335
20.

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Humbert M, Farber HW, Ghofrani HA, Benza RL, Busse D, Meier C, Hoeper MM.

Eur Respir J. 2019 Jun 5;53(6). pii: 1802004. doi: 10.1183/13993003.02004-2018. Print 2019 Jun.

21.

The new haemodynamic definition of pulmonary hypertension: evidence prevails, finally!

Hoeper MM, Humbert M.

Eur Respir J. 2019 Mar 28;53(3). pii: 1900038. doi: 10.1183/13993003.00038-2019. Print 2019 Mar. No abstract available.

PMID:
30923177
22.

Seeing the Forest for the (Arterial) Tree: Vascular Pruning & the COPD Pulmonary Vascular Phenotype.

Weatherald J, Montani D, Humbert M.

Am J Respir Crit Care Med. 2019 Mar 25. doi: 10.1164/rccm.201901-0248ED. [Epub ahead of print] No abstract available.

PMID:
30908925
23.

Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension.

Bunel V, Guyard A, Dauriat G, Danel C, Montani D, Gauvain C, Thabut G, Humbert M, Castier Y, Dorfmüller P, Mal H.

Chest. 2019 Jul;156(1):33-44. doi: 10.1016/j.chest.2019.02.333. Epub 2019 Mar 11.

PMID:
30872017
24.

In vitro PUVA treatment triggers calreticulin exposition and HMGB1 release by dying T lymphocytes in GVHD: New insights in extracorporeal photopheresis.

Coppard C, Hannani D, Humbert M, Gauthier V, Plumas J, Merlin E, Gabert F, Chaperot L.

J Clin Apher. 2019 Mar 12. doi: 10.1002/jca.21698. [Epub ahead of print]

PMID:
30860623
25.

Entry Exclusion of Conjugative Plasmids of the IncA, IncC, and Related Untyped Incompatibility Groups.

Humbert M, Huguet KT, Coulombe F, Burrus V.

J Bacteriol. 2019 Apr 24;201(10). pii: e00731-18. doi: 10.1128/JB.00731-18. Print 2019 May 15.

PMID:
30858294
26.

Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study.

Cornet L, Khouri C, Roustit M, Guignabert C, Chaumais MC, Humbert M, Revol B, Despas F, Montani D, Cracowski JL.

Eur Respir J. 2019 May 9;53(5). pii: 1802472. doi: 10.1183/13993003.02472-2018. Print 2019 May.

PMID:
30846469
27.

PyLAT: Python LAMMPS Analysis Tools.

Humbert MT, Zhang Y, Maginn EJ.

J Chem Inf Model. 2019 Apr 22;59(4):1301-1305. doi: 10.1021/acs.jcim.9b00066. Epub 2019 Mar 15.

PMID:
30844269
28.

Lysyl oxidase-a possible role in systemic sclerosis-associated pulmonary hypertension: a multicentre study.

Vadasz Z, Balbir Gurman A, Meroni P, Farge D, Levi Y, Ingegnoli F, Braun-Moscovici Y, Rosner I, Slobodin G, Rozenbaum M, Jiries N, Kaly L, Boulman N, Zilber K, Ginsberg S, Awisat A, Goldberg Y, Lurie M, Ghigna MR, Guignabert C, Humbert M, Rimar D.

Rheumatology (Oxford). 2019 Feb 15. pii: kez035. doi: 10.1093/rheumatology/kez035. [Epub ahead of print]

PMID:
30770717
29.

Adaptation of an R5 Simian-Human Immunodeficiency Virus Encoding an HIV Clade A Envelope with or without Ablation of Adaptive Host Immunity: Differential Selection of Viral Mutants.

Zhou M, Humbert M, Mukhtar MM, Scinto HB, Vyas HK, Lakhashe SK, Byrareddy SN, Maurer G, Thorat S, Owuor J, Lai Z, Chen Y, Griffiths A, Chenine AL, Gumber S, Villinger F, Montefiori D, Ruprecht RM.

J Virol. 2019 Apr 17;93(9). pii: e02267-18. doi: 10.1128/JVI.02267-18. Print 2019 May 1.

PMID:
30760566
30.

Inhibition of B cell-dependent lymphoid follicle formation prevents lymphocytic bronchiolitis after lung transplantation.

Smirnova NF, Conlon TM, Morrone C, Dorfmuller P, Humbert M, Stathopoulos GT, Umkehrer S, Pfeiffer F, Yildirim AÖ, Eickelberg O.

JCI Insight. 2019 Feb 7;4(3). pii: 123971. doi: 10.1172/jci.insight.123971. [Epub ahead of print]

31.

Therapeutic Modulation of Autophagy in Leukaemia and Lymphoma.

Djavaheri-Mergny M, Giuriato S, Tschan MP, Humbert M.

Cells. 2019 Jan 30;8(2). pii: E103. doi: 10.3390/cells8020103. Review.

32.

Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.

Tu L, Desroches-Castan A, Mallet C, Guyon L, Cumont A, Phan C, Robert F, Thuillet R, Bordenave J, Sekine A, Huertas A, Ritvos O, Savale L, Feige JJ, Humbert M, Bailly S, Guignabert C.

Circ Res. 2019 Mar 15;124(6):846-855. doi: 10.1161/CIRCRESAHA.118.313356.

PMID:
30636542
33.

[Year in review : geriatrics].

Stamm E, Acchini A, Da Costa A, Besse S, Christou F, Launay C, Balmer P, Humbert M, Nguyen S, Major K, Bosshard W, Büla C.

Rev Med Suisse. 2019 Jan 9;15(N° 632-633):50-52. Review. French.

PMID:
30629369
34.

Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension.

Chemla D, Boulate D, Weatherald J, Lau EMT, Attal P, Savale L, Montani D, Fadel E, Mercier O, Sitbon O, Humbert M, Hervé P.

Chest. 2019 May;155(5):991-998. doi: 10.1016/j.chest.2018.12.006. Epub 2018 Dec 27.

PMID:
30594558
35.

Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.

Hautefort A, Mendes-Ferreira P, Sabourin J, Manaud G, Bertero T, Rucker-Martin C, Riou M, Adão R, Manoury B, Lambert M, Boet A, Lecerf F, Domergue V, Brás-Silva C, Gomez AM, Montani D, Girerd B, Humbert M, Antigny F, Perros F.

Circulation. 2019 Feb 12;139(7):932-948. doi: 10.1161/CIRCULATIONAHA.118.033744.

PMID:
30586714
36.

Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases.

Eyries M, Montani D, Nadaud S, Girerd B, Levy M, Bourdin A, Trésorier R, Chaouat A, Cottin V, Sanfiorenzo C, Prevot G, Reynaud-Gaubert M, Dromer C, Houeijeh A, Nguyen K, Coulet F, Bonnet D, Humbert M, Soubrier F.

Eur Respir J. 2019 Mar 14;53(3). pii: 1801371. doi: 10.1183/13993003.01371-2018. Print 2019 Mar.

PMID:
30578383
37.

Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.

Günther S, Bordenave J, Hua-Huy T, Nicco C, Cumont A, Thuillet R, Tu L, Quatremarre T, Guilbert T, Jalce G, Batteux F, Humbert M, Savale L, Guignabert C, Dinh-Xuan AT.

Int J Mol Sci. 2018 Dec 18;19(12). pii: E4105. doi: 10.3390/ijms19124105.

38.

Warming up the tumor microenvironment in order to enhance immunogenicity.

Humbert M, Hugues S.

Oncoimmunology. 2018 Oct 1;8(1):e1510710. doi: 10.1080/2162402X.2018.1510710. eCollection 2019.

39.

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.

Humbert M, Guignabert C, Bonnet S, Dorfmüller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M.

Eur Respir J. 2019 Jan 24;53(1). pii: 1801887. doi: 10.1183/13993003.01887-2018. Print 2019 Jan.

40.

Functional interaction between PDGFβ and GluN2B-containing NMDA receptors in smooth muscle cell proliferation and migration in pulmonary arterial hypertension.

Quatredeniers M, Nakhleh MK, Dumas SJ, Courboulin A, Vinhas MC, Antigny F, Phan C, Guignabert C, Bendifallah I, Vocelle M, Fadel E, Dorfmüller P, Humbert M, Cohen-Kaminsky S.

Am J Physiol Lung Cell Mol Physiol. 2019 Mar 1;316(3):L445-L455. doi: 10.1152/ajplung.00537.2017. Epub 2018 Dec 13.

PMID:
30543306
41.

Biomarker-based corticosteroid adjustment in severe asthma: a modified Delphi consensus.

Gallagher NE, Hanratty CE, Humbert M, Bel E, Djukanovic R, Hudson V, Amos N, Heaney LG.

ERJ Open Res. 2018 Dec 7;4(4). pii: 00081-2018. doi: 10.1183/23120541.00081-2018. eCollection 2018 Oct.

42.

Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis.

Rhodes CJ, Batai K, Bleda M, Haimel M, Southgate L, Germain M, Pauciulo MW, Hadinnapola C, Aman J, Girerd B, Arora A, Knight J, Hanscombe KB, Karnes JH, Kaakinen M, Gall H, Ulrich A, Harbaum L, Cebola I, Ferrer J, Lutz K, Swietlik EM, Ahmad F, Amouyel P, Archer SL, Argula R, Austin ED, Badesch D, Bakshi S, Barnett C, Benza R, Bhatt N, Bogaard HJ, Burger CD, Chakinala M, Church C, Coghlan JG, Condliffe R, Corris PA, Danesino C, Debette S, Elliott CG, Elwing J, Eyries M, Fortin T, Franke A, Frantz RP, Frost A, Garcia JGN, Ghio S, Ghofrani HA, Gibbs JSR, Harley J, He H, Hill NS, Hirsch R, Houweling AC, Howard LS, Ivy D, Kiely DG, Klinger J, Kovacs G, Lahm T, Laudes M, Machado RD, MacKenzie Ross RV, Marsolo K, Martin LJ, Moledina S, Montani D, Nathan SD, Newnham M, Olschewski A, Olschewski H, Oudiz RJ, Ouwehand WH, Peacock AJ, Pepke-Zaba J, Rehman Z, Robbins I, Roden DM, Rosenzweig EB, Saydain G, Scelsi L, Schilz R, Seeger W, Shaffer CM, Simms RW, Simon M, Sitbon O, Suntharalingam J, Tang H, Tchourbanov AY, Thenappan T, Torres F, Toshner MR, Treacy CM, Vonk Noordegraaf A, Waisfisz Q, Walsworth AK, Walter RE, Wharton J, White RJ, Wilt J, Wort SJ, Yung D, Lawrie A, Humbert M, Soubrier F, Trégouët DA, Prokopenko I, Kittles R, Gräf S, Nichols WC, Trembath RC, Desai AA, Morrell NW, Wilkins MR; UK NIHR BioResource Rare Diseases Consortium; UK PAH Cohort Study Consortium; US PAH Biobank Consortium.

Lancet Respir Med. 2019 Mar;7(3):227-238. doi: 10.1016/S2213-2600(18)30409-0. Epub 2018 Dec 5.

43.

Pulmonary arterial hypertension in adults

Bourlier D, Humbert M, Savale L.

Rev Prat. 2017 Dec;67(10):e471-e478. French. No abstract available.

PMID:
30512622
44.

Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.

Poble PB, Phan C, Quatremare T, Bordenave J, Thuillet R, Cumont A, Huertas A, Tu L, Dorfmüller P, Humbert M, Ghigna MR, Savale L, Guignabert C.

FASEB J. 2019 Mar;33(3):3670-3679. doi: 10.1096/fj.201801659R. Epub 2018 Nov 27.

PMID:
30481487
45.

[IL6R is the key therapeutical target in pulmonary arterial hypertension].

Tu L, Phan C, Humbert M, Guignabert C.

Med Sci (Paris). 2018 Oct;34(10):765-768. doi: 10.1051/medsci/2018201. Epub 2018 Nov 19. French. No abstract available.

PMID:
30451672
46.

[Staying at home : which dimensions to assess in older persons ?]

Büla C, Humbert M, Nguyen S, Major K, Joly Schwartz C.

Rev Med Suisse. 2018 Nov 7;14(626):1993-1997. French.

PMID:
30422417
47.

Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension.

Bohnen MS, Ma L, Zhu N, Qi H, McClenaghan C, Gonzaga-Jauregui C, Dewey FE, Overton JD, Reid JG, Shuldiner AR, Baras A, Sampson KJ, Bleda M, Hadinnapola C, Haimel M, Bogaard HJ, Church C, Coghlan G, Corris PA, Eyries M, Gibbs JSR, Girerd B, Houweling AC, Humbert M, Guignabert C, Kiely DG, Lawrie A, MacKenzie Ross RV, Martin JM, Montani D, Peacock AJ, Pepke-Zaba J, Soubrier F, Suntharalingam J, Toshner M, Treacy CM, Trembath RC, Vonk Noordegraaf A, Wharton J, Wilkins MR, Wort SJ, Yates K, Gräf S, Morrell NW, Krishnan U, Rosenzweig EB, Shen Y, Nichols CG, Kass RS, Chung WK.

Circ Genom Precis Med. 2018 Oct;11(10):e002087. doi: 10.1161/CIRCGEN.118.002087.

48.

Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?

Lambert M, Capuano V, Olschewski A, Sabourin J, Nagaraj C, Girerd B, Weatherald J, Humbert M, Antigny F.

Int J Mol Sci. 2018 Oct 14;19(10). pii: E3162. doi: 10.3390/ijms19103162. Review.

49.

Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease.

Turpin M, Chantalat-Auger C, Parent F, Driss F, Lionnet F, Habibi A, Maître B, Huertas A, Jaïs X, Weatherald J, Montani D, Sitbon O, Simonneau G, Galactéros F, Humbert M, Bartolucci P, Savale L.

Eur Respir J. 2018 Oct 10;52(4). pii: 1800272. doi: 10.1183/13993003.00272-2018. Print 2018 Oct.

PMID:
30305330
50.

Structure of the Recombinant Neisseria gonorrhoeae Adhesin Complex Protein (rNg-ACP) and Generation of Murine Antibodies with Bactericidal Activity against Gonococci.

Almonacid-Mendoza HL, Humbert MV, Dijokaite A, Cleary DW, Soo Y, Hung MC, Orr CM, Machelett MM, Tews I, Christodoulides M.

mSphere. 2018 Oct 10;3(5). pii: e00331-18. doi: 10.1128/mSphere.00331-18.

Supplemental Content

Loading ...
Support Center